Novel CD8+ T Cell Antagonists Based on β2-Microglobulin*

The CD8 coreceptor of cytotoxic T lymphocytes binds to a conserved region of major histocompatibility complex class I molecules during recognition of peptide-major histocompatibility complex (MHC) class I antigens on the surface of target cells. This event is central to the activation of cytotoxic T lymphocyte (CTL) effector functions. The contribution of the MHC complex class I light chain, β2-microglobulin, to CD8αα binding is relatively small and is mediated mainly through the lysine residue at position 58. Despite this, using molecular modeling, we predict that its mutation should have a dramatic effect on CD8αα binding. The predictions are confirmed using surface plasmon resonance binding studies and human CTL activation assays. Surprisingly, the charge-reversing mutation, Lys58 → Glu, enhances β2m-MHC class I heavy chain interactions. This mutation also significantly reduces CD8αα binding and is a potent antagonist of CTL activation. These results suggest a novel approach to CTL-specific therapeutic immunosuppression.

[1]  P. Klenerman,et al.  Direct Ex Vivo Measurement of CD8+T-Lymphocyte Responses to Human Parvovirus B19 , 2001, Journal of Virology.

[2]  S. Rowland-Jones,et al.  Antigen–specific release of β-chemokines by anti-HIV-1 cytotoxic T lymphocytes , 1998, Current Biology.

[3]  G. Gao,et al.  Production of soluble αβ T‐cell receptor heterodimers suitable for biophysical analysis of ligand binding , 2008, Protein science : a publication of the Protein Society.

[4]  Ryuji Kubota,et al.  The Effect of Human β2-Microglobulin on Major Histocompatibility Complex I Peptide Loading and the Engineering of a High Affinity Variant , 1998, The Journal of Biological Chemistry.

[5]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[6]  J. Bell,et al.  BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation. , 1999, Analytical biochemistry.

[7]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[8]  J. Bell,et al.  Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment , 1995, The Journal of experimental medicine.

[9]  G. Gao,et al.  Antagonism of cytotoxic T-lymphocyte activation by soluble CD8 , 1999, Nature Medicine.

[10]  M. Karplus,et al.  Trypsinogen-trypsin transition: a molecular dynamics study of induced conformational change in the activation domain. , 1987, Biochemistry.

[11]  D. Price,et al.  Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. , 1999, Journal of immunology.

[12]  P. Earl,et al.  Recombinant vaccinia viruses , 1999, Molecular biotechnology.

[13]  K. Rock,et al.  Reassociation with beta 2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptides. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Bell,et al.  Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Ogg,et al.  Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma. , 1999, Journal of immunology.

[16]  Peter A. Kollman,et al.  FREE ENERGY CALCULATIONS : APPLICATIONS TO CHEMICAL AND BIOCHEMICAL PHENOMENA , 1993 .

[17]  V. Appay,et al.  A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex. , 2001, Immunity.

[18]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[19]  Andrew K. Sewell,et al.  The Human CD8 Coreceptor Effects Cytotoxic T Cell Activation and Antigen Sensitivity Primarily by Mediating Complete Phosphorylation of the T Cell Receptor ζ Chain* , 2001, The Journal of Biological Chemistry.

[20]  D. Wiley,et al.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M Karplus,et al.  Solvent effects on protein motion and protein effects on solvent motion. Dynamics of the active site region of lysozyme. , 1989, Journal of molecular biology.